Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National, Institutes of Health, Bethesda, Maryland, United States of America.
Philips, Best, The Netherlands.
PLoS One. 2023 Aug 4;18(8):e0289674. doi: 10.1371/journal.pone.0289674. eCollection 2023.
Heat-induced destruction of cancer cells via microwave ablation (MWA) is emerging as a viable treatment of primary and metastatic liver cancer. Prediction of the impacted zone where cell death occurs, especially in the presence of vasculature, is challenging but may be achieved via biophysical modeling. To advance and characterize thermal MWA for focal cancer treatment, an in vivo method and experimental dataset were created for assessment of biophysical models designed to dynamically predict ablation zone parameters, given the delivery device, power, location, and proximity to vessels.
MWA zone size, shape, and temperature were characterized and monitored in the absence of perfusion in ex vivo liver and a tissue-mimicking thermochromic phantom (TMTCP) at two power settings. Temperature was monitored over time using implanted thermocouples with their locations defined by CT. TMTCPs were used to identify the location of the ablation zone relative to the probe. In 6 swine, contrast-enhanced CTs were additionally acquired to visualize vasculature and absence of perfusion along with corresponding post-mortem gross pathology.
Bench studies demonstrated average ablation zone sizes of 4.13±1.56cm2 and 8.51±3.92cm2, solidity of 0.96±0.06 and 0.99±0.01, ablations centered 3.75cm and 3.5cm proximal to the probe tip, and temperatures of 50 ºC at 14.5±13.4s and 2.5±2.1s for 40W and 90W ablations, respectively. In vivo imaging showed average volumes of 9.8±4.8cm3 and 33.2±28.4cm3 and 3D solidity of 0.87±0.02 and 0.75±0.15, and gross pathology showed a hemorrhagic halo area of 3.1±1.2cm2 and 9.1±3.0cm2 for 40W and 90W ablations, respectfully. Temperatures reached 50ºC at 19.5±9.2s and 13.0±8.3s for 40W and 90W ablations, respectively.
MWA results are challenging to predict and are more variable than manufacturer-provided and bench predictions due to vascular stasis, heat-induced tissue changes, and probe operating conditions. Accurate prediction of MWA zones and temperature in vivo requires comprehensive thermal validation sets.
通过微波消融(MWA)诱导的热破坏来治疗原发性和转移性肝癌,这一方法正逐渐成为一种可行的治疗手段。预测发生细胞死亡的影响区域,特别是在存在脉管系统的情况下,具有挑战性,但可以通过生物物理建模来实现。为了推进和表征针对局部癌症治疗的热 MWA,创建了一种体内方法和实验数据集,用于评估设计用于动态预测消融区域参数的生物物理模型,这些参数基于输送设备、功率、位置和靠近血管的位置。
在不存在灌注的情况下,在离体肝脏和组织模拟热敏变色体模(TMTCP)中,在两种功率设置下对 MWA 区域的大小、形状和温度进行了表征和监测。使用植入式热电偶随时间监测温度,并用 CT 定义其位置。TMTCP 用于确定消融区相对于探头的位置。在 6 头猪中,还获得了对比增强 CT 以可视化血管和无灌注情况,并进行相应的死后大体病理学检查。
台架研究表明,在 40W 和 90W 消融中,平均消融区域大小分别为 4.13±1.56cm2 和 8.51±3.92cm2,形态为 0.96±0.06 和 0.99±0.01,消融中心分别位于探头尖端近端 3.75cm 和 3.5cm,50°C 的温度分别在 14.5±13.4s 和 2.5±2.1s 时达到,消融区域的平均体积分别为 9.8±4.8cm3 和 33.2±28.4cm3,3D 形态分别为 0.87±0.02 和 0.75±0.15,大体病理学显示 40W 和 90W 消融的出血晕环区域分别为 3.1±1.2cm2 和 9.1±3.0cm2。40W 和 90W 消融的温度分别在 19.5±9.2s 和 13.0±8.3s 时达到 50°C。
由于血管停滞、热诱导的组织变化和探头操作条件,MWA 结果难以预测,并且比制造商提供的和台架预测的更具变异性。要在体内准确预测 MWA 区域和温度,需要全面的热验证集。